Digital FH25: The art of connection at Frontiers Health with Aline N... Aline Noizet, founder of Digital Health Connector, talks with Deep Dive editor Eloise McLennan about the relationships that make innovation possible.
Market Access Policy in focus: Trump’s Most Favoured Nations drug pricing ... Alice Valder Curran, a partner at Hogan Lovells, provides an update on what's happening right now with Most Favoured Nations drug pricing.
Patients FH25: Exploring the intersection of patients, HCPs, and tech... In a new FH25 podcast, Denise Silber, founder of Basil Strategies and Doctors 2.0, discusses the intersection of HCPs, patients, and technology.
Oncology Doing good in people’s lives: Amy Burroughs discusses CML Amy Burroughs, CEO, Terns Pharmaceuticals, discusses available treatments for CML, the potential of allosteric TKIs, and the wider oncology landscape.
Sales & Marketing FH25: Individual centric investing with Steve Seuntjens In a new FH25 podcast episode, Deep Dive editor Eloise McLennan speaks with Steve Seuntjens, Partner at PHS Capital.
Sales & Marketing Pharma and health advertising: Brian Coane on the necessity ... Brian Coane, health partner at Leith, talks sensitivity, maximum impact, and overcoming the fear of getting humour in pharma advertising wrong.
News After internal setbacks, Pfizer buys obesity player Metsera Pfizer's answer to a string of disappointing projects in obesity R&D? Bolt on a promising pipeline from another developer.
Sales & Marketing FH25: Individual centric investing with Steve Seuntjens In a new FH25 podcast episode, Deep Dive editor Eloise McLennan speaks with Steve Seuntjens, Partner at PHS Capital.